Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MM-093 in Active Rheumatoid Arthritis
NCT00105976Phase 2Completed
- Sponsor
- Merrimack Pharmaceuticals
- Start
- Feb 2005
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant human alpha-fetoprotein in rheumatoid arthritis (RA), sponsored by Merrimack Pharmaceuticals. Started Feb 2005; status: completed.
02
Drugs
recombinant human alpha-fetoprotein
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00105976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00105976.